NCT03650010 is a clinical trial of Total ankle replacement in Ankle Arthritis, sponsored by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio.

Who is sponsoring NCT03650010?

NCT03650010 is sponsored by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio.

What drugs are being tested in NCT03650010?

Interventions in NCT03650010: Total ankle replacement.

What condition does NCT03650010 study?

NCT03650010 studies Ankle Arthritis.

Is NCT03650010 still recruiting?

NCT03650010 is currently recruiting now. Last updated 28 August 2018.

Last reviewed 2018-08-28 · How we verify

NCT03650010

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Total Ankle Replacement: Clinical and Radiological Outcomes

Recruiting now Last updated 28 August 2018

What this trial tests

trial testing Total ankle replacement in Ankle Arthritis in 1,066 participants. Currently enrolling.

Timeline

11 May 2016

Primary endpoint
31 March 2026

31 March 2027

Quick facts

Lead sponsor	I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	1,066
Start date	11 May 2016
Primary completion	31 March 2026
Estimated completion	31 March 2027
Sites	1 location across Italy

Drugs / interventions tested

Total ankle replacement

Conditions studied

Ankle Arthritis — all drugs for Ankle Arthritis →

Sponsor

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio — full company profile →

Who can join

18 and older, any sex, with Ankle Arthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This retrospective and prospective study intends to evaluate the epidemiology and effectiveness of ankle joint surgery in patients operated from January 2011 to March 2026, evaluating the results both clinically and radiographically.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio trials

Trials by the same sponsor.

NCT07386405 — Validation and Cultural Adaptation of the KOOS-ACL Scale for the Italian Population · not yet recruiting
NCT07352111 — High-risk Coronary Atherosclerosis in Subjects With Family History of Myocardial Infarction · NA · recruiting
NCT07304323 — Prepare II - Predictive Model Training and External Validation · recruiting
NCT07337499 — Comparison of Maglumi X3 SNIBE With Other Analytical Methods in Laboratory Medicine for 25-(OH)D Quantification · recruiting
NCT06940245 — Use of Virtual Reality for the Assessment of Attentional and Reaction Abilities for Fall Risk Evaluation · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03650010 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Last refreshed: 28 August 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03650010.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing